# Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA

> **NCT03054064** · NA · COMPLETED · sponsor: **Parker Hannifin Corporation** · enrollment: 48 (actual)

## Conditions studied

- Cerebrovascular Accident (CVA)
- Stroke
- Hemiplegia

## Interventions

- **DEVICE:** Indego Exoskeleton

## Key facts

- **NCT ID:** NCT03054064
- **Lead sponsor:** Parker Hannifin Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-21
- **Primary completion:** 2017-12-28
- **Final completion:** 2018-01-17
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03054064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03054064, "Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03054064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*